Kim, S.-W., Yu, Y.-M., Piao, C.S., Kim, J.-B. & Lee, J.-K. (2004) Inhibition of
delayed induction of p38 mitogen-activated protein kinase attenuates kainic
acid-induced neuronal loss in the hippocampus. Brain Res., 1007, 188–191.
Korzus, E., Rosenfeld, M.G. & Mayford, M. (2004) CBP histone acetyltransferase activity is a critical component of memory consolidation. Neuron,
42, 961–972.
Le Gal La Salle, G. (1988) Long-lasting and sequential increase of c-fos
oncoprotein expression in kainic acid-induced status epilepticus. Neurosci.
Lett., 88, 127–130.
Li, J., Guo, Y., Schroeder, F.A., Youngs, R.M., Schmidt, T.W., Ferris, C.,
Konradi, C. & Akbarian, S. (2004) Dopamine D2-like antagonists induce
chromatin remodeling in striatal neurons through cyclic AMP-protein kinase
A and NMDA receptor signaling. J. Neurochem., 90, 1117–1131.
Liu, H.M., Lei, D.L. & Yang, D.L. (1996) Kainate-induced brain lesion: similar
local and remote histopathological and molecular changes as in ischemic
brain infarct. J. Neuropathol. Exp. Neurol., 55, 787–794.
Lothman, E.W. & Collins, R.C. (1981) Kainic acid induced limbic seizures:
metabolic, behavioral, electroencephalographic and neuropathological correlates. Brain Res., 218, 299–318.
Nowak, S.J. & Corces, V.G. (2000) Phosphorylation of histone H3 correlates
with transcriptionally active loci. Genes Dev., 14, 3003–3013.
Ogryzko, V.V., Schiltz, R.L., Russanova, V., Howard, B.H. & Nakatani, Y.
(1996) The transcriptional coactivators p300 and CBP are histone
acetyltransferases. Cell, 87, 953–959.
Pan, M.H., Huang, T.M. & Lin, J.K. (1999) Biotransformation of curcumin
through reduction and glucuronidation in mice. Drug Metab. Dispos., 4,
486–494.
Panegyres, P.K. & Hughes, J. (1997) The anticonvulsant properties of antisense
c-fos oligodeoxynucleotides in kainic acid-induced seizures. J. Neurol. Sci.,
153, 12–19.
